BMS Names Head of Business Development

From DCAT Value Chain Insights (VCI)

By People On The Move posted 10-20-2015 12:41


Bristol-Myers Squibb has appointed Paul Biondi as senior vice president and head of business development and will report to Charlie Bancroft, chief financial officer. In this role, Biondi will lead the development of strategic partnerships and pursue scientific innovations across commercial, development, discovery, and technology platforms to complement the company’s internal R&D pipeline. Biondi most recently served as senior vice president, head of R&D operations, Bristol-Myers Squibb.

As head of R&D Operations, Biondi led an organization focused on optimizing delivery of the company’s pipeline, managing the company’s R&D portfolio and project management as well as early- and late-stage clinical operations providing strategic insights and operational excellence across R&D. He also had responsibility for cross R&D efforts around strategy, analytics, continuous improvement, learning and collaboration. Biondi served as a member of Bristol-Myers Squibb's R&D Senior Leadership Team, Deal Review Committee and is a member of the board of directors of Transcelerate Biopharma Inc.

Biondi joined Bristol-Myers Squibb in 2002 and was appointed vice president of R&D Operations when it was formed in May 2005. He was promoted to senior vice president of R&D Operations in 2010 and has taken on increasing levels of responsibility.

Source: Bristol-Myers Squibb


Thank you for reading DCAT Value Chain Insights (VCI), an information resource from the
Drug, Chemical & Associated Technologies Association (DCAT). 

Learn more and sign up to receive a complimentary subscription